Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Alteration of CD1 expression in multiple sclerosis.
Variables associated with patient activation in persons with multiple sclerosis.
Naltrexone prescribing information
Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome.
Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R.
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases.
Reward responsiveness and fatigue in multiple sclerosis.
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.
Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders.
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.
The histaminergic network in the brain: basic organization and role in disease.
Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
Historical Issues of Optic neuritis and Sensory Disorder in Persian Traditional Medicine.
Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.
Does fatigue occur in MS patients without disability? Suggested running head: Fatigue and disability in MS.
A randomized trial of stress management for the prevention of new brain lesions in MS.
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.
Pages
« first
‹ previous
…
180
181
182
183
184
185
186
187
188
…
next ›
last »